top of page
PRIMARY SCLEROSING CHOLANGITIS
PATIENT REGISTRY
Supported browsers: Chrome, Edge, and Safari
News and Announcements
Search
PRIMIS (Phase 3 Study of Cilofexor) News from EASL Congress 2023
News from the EASLCongress 2023 meeting in Vienna From the "late-breaking" abstract session on June 24, 2023, results of the pre-planned...
Jun 24, 2023


Oral Vancomycin and Insurance Coverage
Survey Results: Oral Vancomycin and Insurance Coverage PSC Partners received a request from patients to survey the PSC patient community...
Feb 27, 2023


The VIADUCT Newsletter Issue 5
Issue 5 - October 2022 Welcome! In this issue: • From the Registry Director • The Clinical Trial Landscape in PSC • Current International PSC Research • The ChiLDRen Study • Gilead's PRIMUS Trial Terminated • Patient-friendly Clinical Trial Design • Highlights of the 2022 International Liver Congress • Meet PSCP's Ruth-Anne Pai, PhD • Clinical Trials Are Recruiting From the Registry Director Dear Registry Participants, Whether you are a person living with PSC, or the relat
Oct 30, 2022


PRIMIS (Phase 3 Study of Cilofexor) News
Statement From Gilead Sciences on September 27, 2022 Early Termination of Gilead-Sponsored Study GS-US-428-4194: A Phase 3, Randomized,...
Sep 28, 2022
The VIADUCT Newsletter Issue 4
In this issue: • From the Registry Director • Mini-PFDDs • Patient Registry Video Tour • Help Us Grow & Diversify the Registry! • PSC Partners WIND Natural History Project • ROADMAP Wrap-up • PSC Research: Collaborative Efforts From the Registry Director Dear Registry Participants, Excitement is mounting as we approach the 18th PSC Partners Annual Conference, which is being planned in collaboration with Brigham and Women's and Massachusetts General hospitals (Harvard Univers
May 25, 2022


bottom of page
